Karaca, B. Et Al. 2013. Combination of AT-101/cisplatin overcomes chemoresistance by inducing apoptosis and modulating epigenetics in human ovarian cancer cells. Molecular Biology Reports , vol.40, no.6 , 3925-3933.

Karaca, B., ATMACA İLHAN, H., Bozkurt, E., Kisim, A., Uzunoglu, S., Karabulut, B., ... Sezgin, C.(2013). Combination of AT-101/cisplatin overcomes chemoresistance by inducing apoptosis and modulating epigenetics in human ovarian cancer cells. Molecular Biology Reports , vol.40, no.6, 3925-3933.

Karaca, Burcak Et Al. "Combination of AT-101/cisplatin overcomes chemoresistance by inducing apoptosis and modulating epigenetics in human ovarian cancer cells," Molecular Biology Reports , vol.40, no.6, 3925-3933, 2013

Karaca, Burcak Et Al. "Combination of AT-101/cisplatin overcomes chemoresistance by inducing apoptosis and modulating epigenetics in human ovarian cancer cells." Molecular Biology Reports , vol.40, no.6, pp.3925-3933, 2013

Karaca, B. Et Al. (2013) . "Combination of AT-101/cisplatin overcomes chemoresistance by inducing apoptosis and modulating epigenetics in human ovarian cancer cells." Molecular Biology Reports , vol.40, no.6, pp.3925-3933.

@article{article, author={Burcak Karaca Et Al. }, title={Combination of AT-101/cisplatin overcomes chemoresistance by inducing apoptosis and modulating epigenetics in human ovarian cancer cells}, journal={Molecular Biology Reports}, year=2013, pages={3925-3933} }